Our news

  • Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.Our latest newsletter (Summer 2022) is now availableIf you have feedback on current or past newsletters, or suggestions for future newsletter topics,...
    August 10 2022
  • Eduard Shantsila, Monika Kozieł-Siołkowska, Gregory LipReview questionWe reviewed the evidence that examined whether antiplatelet agents reduced total deaths or major thrombotic events or both in patients with elevated blood pressure (BP) when compared to placebo or other active treatment. We also assessed whether oral anticoagulants reduced total...
    August 9 2022
  • A new chapter for CochraneCochrane has embarked on an important change programme to transform the way we produce the high-quality, independent and timely evidence. The new model is designed to ensure Cochrane remains viable, sustainable, and focused on the greatest global health and care challenges now and into the future. As part of the...
    June 27 2022
  • Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.Our latest newsletter (Spring 2022) is now availableIf you have feedback on current or past newsletters, or suggestions for future newsletter topics,...
    April 22 2022
  • Plain language summary:Review questionWe wanted to find out the effects of calcium intake on blood pressure in people with normal blood pressure. BackgroundHypertension is a serious health problem that increases the risk of heart and kidney diseases. Several studies have shown that increasing calcium intake lowers blood pressure even in...
    March 1 2022
  • Plain language conclusions:BackgroundHypertension or elevated blood pressure is a major risk factor for cardiovascular diseases, such as coronary heart disease, stroke, and heart failure. Lowering blood pressure to normal levels is effective in reducing the risks of these diseases. Many of the risk factors relating to hypertension, such as...
    March 1 2022
  • Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.Our latest newsletter (Winter 2022) is now availableIf you have feedback on current or past newsletters, or suggestions for future newsletter topics,...
    February 28 2022
  • Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.Our latest newsletter (Autumn 2021) is now availableIf you have feedback on current or past newsletters, or suggestions for future newsletter topics,...
    November 5 2021
  • Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.Our latest newsletter (Summer 2021) is now availableIf you have feedback on current or past newsletters, or suggestions for future newsletter topics,...
    September 5 2021
  • Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.Our latest newsletter (Spring 2021) is now availableIf you have feedback on current or past newsletters, or suggestions for future newsletter topics,...
    May 1 2021

Pages

Subscribe to Our news